دورية أكاديمية

Post-finasteride syndrome

التفاصيل البيبلوغرافية
العنوان: Post-finasteride syndrome
المؤلفون: Ana Francisca Junqueira Ribeiro Pereira, Thaissa Oliveira de Almeida Coelho
المصدر: Anais Brasileiros de Dermatologia, Vol 95, Iss 3, Pp 271-277 (2020)
بيانات النشر: Sociedade Brasileira de Dermatologia, 2020.
سنة النشر: 2020
المجموعة: LCC:Dermatology
مصطلحات موضوعية: 5-Alpha reductase inhibitors, Alopecia, Finasteride, Dermatology, RL1-803
الوصف: Abstract Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related reactions that persisted for at least three months after discontinuation of this drug, and the term post-finasteride syndrome arose. It includes persistent sexual, neuropsychiatric, and physical symptoms. Studies to date cannot refute or confirm this syndrome as a nosological entity. If it actually exists, it seems to occur in susceptible people, even if exposed to small doses and for short periods, and symptoms may persist for long periods. Based on currently available data, the use of 5α-reductase inhibitors in patients with a history of depression, sexual dysfunction, or infertility should be carefully and individually assessed.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Portuguese
تدمد: 0365-0596
Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000300001&tlng=en; http://www.scielo.br/pdf/abd/v95n3/0365-0596-abd-95-03-0271.pdf; https://doaj.org/toc/0365-0596
DOI: 10.1016/j.abd.2020.02.001
URL الوصول: https://doaj.org/article/72ec3ebc94b649c889b6ac071870e70f
رقم الأكسشن: edsdoj.72ec3ebc94b649c889b6ac071870e70f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:03650596
DOI:10.1016/j.abd.2020.02.001